Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 5, 2003, Pages 1555-1559

  Gayet, Stéphane ^a   Chollet, Renaud ^a   Molle, Gérard ^b   Pagès, Jean Marie ^a   Chevalier, Jacqueline ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIFLAVINE; AMIKACIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; GENTAMICIN; IMIPENEM; KANAMYCIN; MEMBRANE PROTEIN; NALIDIXIC ACID; NORFLOXACIN; OUTER MEMBRANE PROTEIN; PHENYLALANINE DERIVATIVE; PROTEIN LAMB; PROTEIN OMPX; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG ACCUMULATION; ENTEROBACTER AEROGENES; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL;

BACTERIAL OUTER MEMBRANE PROTEINS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CELL MEMBRANE PERMEABILITY; CHLORAMPHENICOL; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER AEROGENES; ESCHERICHIA COLI PROTEINS; HUMANS; HYDROLASES; RECEPTORS, VIRUS;

EID: 0038673589     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.5.1555-1559.2003     Document Type: Article

References (47)

1. Alekshun, M. N., and S. B. Levy. 1999. Alteration of the repressor activity of MarR, the negative regulator of the Escherichia coli marRAB locus, by multiple chemicals in vitro. J. Bacteriol. 181:4669-4672.
2. Aleskshun, M. N., and S. B. Levy. 1997. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob. Agents Chemother. 41:2067-2075.
3. Aono, R., N. Tsukagoshi, and M. Yamamoto. 1998. Involvement of outer membrane protein TolC, a possible member of the mar-sox regulon, in maintenance and improvement of organic solvent tolerance of Escherichia coli K-12. J. Bacteriol. 180:938-944.
4. Ardanuy, C., J. Linares, M. A. Dominguez, S. Hernandez-Allés, V. J. Benedi, and L. Martinez-Martinez. 1998. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob. Agents Chemother. 42:1636-1640.
5. Arpin, C., C. Coze, A. M. Rogues, J. P. Gachis, C. Bebear, J. P. Bebear, and C. Quentin. 1996. Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in medical intensive care units. J. Clin. Microbiol. 34:2163-2169.
6. Aucken, H. M., and T. L. Pitt. 1993. Lipopolysaccharide profile typing as a technique for comparative typing of gram-negative bacteria. J. Clin. Microbiol. 31:1286-1289.
7. Barbosa, T. M., and S. B. Levy. 2000. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J. Bacteriol. 182:3467-3474.
8. Bloch, M. A., and C. Desaymard. 1985. Antigenic polymorphism of the LamB protein among members of the family Enterobacteriaceae. J. Bacteriol. 163:106-110.
9. Boos, W., and H. Shuman. 1998. Maltose/maltodextrin system of Escherichia coli: transport, metabolism, and regulation. Microbiol. Mol. Biol. Rev. 62:204-229.
10. Bornet, C., A. Davin-Regli, C. Bosi, J.-M. Pagès, and C. Bollet. 2000. Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J. Clin. Microbiol. 38:1048-1052.
11. Brisse, S., D. Milatovic, A. D. C. Fluit, J. Verhoef, N. Martin, S. Schuring, K. Köhrer, and F. J. Schmitz. 1999. Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovofloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and a Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins. Antimicrob. Agents Chemother. 43:2051-2055.
12. Charrel, R. N., J.-M. Pagès, P. De Micco, and M. Malléa. 1996. Prevalence of outer membrane porin alteration in β-lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob. Agents Chemother. 40:2854-2858.
13. Chevalier, J., J.-M. Pagès, and M. Malléa. 1999. In vivo modification of porin activity conferring antibiotic resistance to Enterobacter aerogenes. Biochem. Biophys. Res. Commun. 266:248-251.
14. Click, E. M., and C. A. Schnaitman. 1989. Export-defective LamB protein is a target for translational control caused by OmpC porin overexpression. J. Bacteriol. 171:616-619.
15. Cloeckaert, A., S. Baucheron, and E. Chaslus-Dancla. 2001. Nonenzymatic chloramphenicol resistance mediated by IncC plasmid R55 is encoded by a floR gene variant. Antimicrob. Agents Chemother. 45:2381-2382.
16. Cohen, S. P., L. M. McMurry, and S. B. Levy. 1988. marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J. Bacteriol. 170:5416-5422.
17. Davin-Regli, A., D. Monnet, P. Saux, C. Bosi, R. Charrel, A. Barthelemy, and C. Bollet. 1996. Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units. J. Clin. Microbiol. 34:1474-1480.
18. Dé, E., A. Baslé, M. Jaquinod, N. Saint, M. Malléa, G. Molle, and J.-M. Pagès. 2001. A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol. Microbiol. 41:189-198.
19. De Gheldre, Y., M. J. Struelens, Y. Glupczynski, P. De Mol, N. Maes, C. Nonhoff, H. Chetoui, C. Sion, O. Ronveaux, M. Vaneechoute, and le Groupement pour le Dépistage, l'Etude et la Prévention des Infections Hospitalières (GDEPIH-GOSPIZ). 2001. National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals. J. Clin. Microbiol. 39:889-896.
20. Diedrich, D. L., and J. A. Fralick. 1982. Relationship between the OmpC and LamB proteins of Escherichia coli and its influence on the protein mass of the outer membrane. J. Bacteriol. 149:156-160.
21. Ferenci, T., and K. S. Lee. 1986. Exclusion of high-molecular-weight maltosaccharides by lipopolysaccharide O-antigen of Escherichia coli and Salmonella typhimurium. J. Bacteriol. 167:1081-1082.
22. Gambino, L., S. J. Gracheck, and P. F. Miller. 1993. Overexpression of the MarA positive regulator is sufficient to confer multiple antibiotic resistance in Escherichia coli. J. Bacteriol. 175:2888-2894.
23. George, A. M., R. M. Hall, and H. W. Stockes. 1995. Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology 141:1909-1920.
24. Hernandez-Allès, S., M. C. Conejo, A. Pascual, J. M. Tomas, V. J. Benedi, and L. Martinez-Martinez. 2000. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J. Antimicrob. Chemother. 46:273-277.
25. Hitchcock, P. J., and T. M. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
26. Laird, M. W., A. W. Kloser, and R. Misra. 1994. Assembly of LamB and OmpF in deep rough lipopolysaccharide mutants of Escherichia coli K-12. J. Bacteriol. 176:2259-2264.
27. Lomovskaya, O., M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V. J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
28. Malléa, M., J. Chevalier, A. Eyraud, A., and J.-M. Pagès. 2002. Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains. Biochem. Biophys. Res. Commun. 293:1370-1373.
29. Malléa, M., J. Chevalier, C. Bornet, A. Eyraud, A. Davin-Regli, C. Bollet, and J.-M. Pagès. 1998. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 144:3003-3009.
30. Malléa, M., V. Simonet, L. Eun-Hee, R. Gervier, E. Collatz, L. Gutmann, and J.-M. Pagès. 1995. Biological and immunological comparisons of Enterobacter cloacae and Escherichia coli porins. FEMS Microbiol. Lett. 129:273-280.
31. Mammeri, H., G. Laurans, M. Eveillard, S. Castelain, and F. Eb. 2001. Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital. J. Clin. Microbiol. 39:2184-2190.
32. Martinez, M. B., M. Flickinger, L. A. Higgins, T. Krick, and G. L. Nelsestuen. 2001. Reduced outer membrane permeability of Escherichia coli O157: H7: suggested role of modified outer membrane porins and theoretical function in resistance to antimicrobial agents. Biochemistry 40:11965-11974.
33. Matsudaira, P. 1987. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 262:10035-10038.
34. McMurry, L. M., A. M. George, and S. B. Levy. 1994. Active efflux of chloramphenicol in susceptible Escherichia coli strains and in multiple-antibiotic-resistant (Mar) mutants. Antimicrob. Agents Chemother. 38:542-546.
35. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standards. NCCLS document M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
36. Nikaido, H., M. Basina, V. Nguyen, and E. Y. Rosenberg. 1998. Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those β-lactam antibiotics containing lipophilic side chains. J. Bacteriol. 180:4686-4692.
37. Nikaido, H., and M. Vaara. 1985. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49:1-32.
38. Pitout, J. D. D., E. S. Moland, C. C. Sanders, K. S. Thomson, and S. R. Fitzsimmons. 1997. β-Lactamases and detection of β-lactam resistance in Enterobacter spp. Antimicrob. Agents Chemother. 41:35-39.
39. Pomposiello, P. J., M. H. J. Bennik, and B. Demple. 2001. Genome-wide transcriptional profiling of the Escherichia coli responses to superoxide stress and sodium salicylate. J. Bacteriol. 183:3890-3902.
40. Randall, L. P., and M. J. Woodward. 2001. Multiple antibiotic resistance (mar) locus in Salmonella enterica serovar Typhimurium DT104. Appl. Environ. Microbiol. 67:1190-1197.
41. Ried, G., I. Hindennach, and U. Henning. 1990. Role of lipopolysaccharide in assembly of Escherichia coli outer membrane proteins OmpA, OmpC, and OmpF. J. Bacteriol. 172:6048-6053.
42. Simonet, V., M. Malléa, D. Fourel, J. M. Bolla, and J.-M. Pagès. 1996. Crucial domains are conserved in Enterobacteriaceae porins. FEMS Microbiol. Lett. 136:91-97.
43. Stoorvogel, J., M. J. A. W. M. Van Bussel, and J. A. M. Van De Klundert. 1991. Biological characterization of an Enterobacter cloacae outer membrane protein (OmpX). J. Bacteriol. 173:161-167.
44. Tsai, C.-M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
45. Tzouveleskis, L. S., E. Tzelepi, M. E. Kauffmann, and A. F. Mentis. 1994. Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes. J. Med. Microbiol. 40:403-407.
46. Walker, C. W., and D. F. J. Brown. 1988. The reliability of methods for detecting chloramphenicol resistance in Haemophilus influenzae. J. Antimicrob. Chemother. 22:905-910.
47. Weigel, L. M., C. D. Steward, and F. C. Tenover. 1998. GyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob. Agents Chemother. 42:2661-2667.